The effect of Online acceptance and commitment therapy (ACT) on depression, quality of life, health-related behaviors and treatment adherence in patients with Parkinson's disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250202064612N1

Enrollment

Registered

2025-08-25

Start date

2025-07-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Well-Being in Parkinson patients. Parkinson's disease

Interventions

Intervention 1: Intervention group:Participants in this group are patients with Parkinson’s disease who will receive Acceptance and Commitment Therapy (ACT) delivered via telehealth. The intervention

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Diagnosis of Parkinson's disease by a specialist doctor Willingness and ability to participate in online sessions (voice calls), and commitment to complete therapy sessions The ability to communicate and understand the Persian language

Exclusion criteria

Exclusion criteria: Having a severe psychological disorder such as a psychotic disorder or severe personality disorder Inability to complete measurement instruments such as questionnaires or inability to attend therapy sessions Use of antidepressants or receiving psychological therapy concurrently with study treatment within the last 6 months

Design outcomes

Primary

Measure	Time frame
Decrease of depression- increase of Quality of life and health-related behaviors and treatment adherence. Timepoint: Pre-test and post-test and three-month follow-up. Method of measurement: Beck Depression Inventory (BDI-II), Parkinson's Disease Quality of Life Questionnaire (PDQ-39), Health Behavior Self-Efficacy Questionnaire, Commitment to Treatment Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Farzaneh

Mashhad University of Medical Sciences

h.farzane@hakimtoos.ac.ir+98 991 994 6489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026